Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia
Restricted accessResearch articleFirst published online January 8, 2019
Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia
Progranulin (GRN) gene mutations are a major cause of frontotemporal dementia (FTD). Most mutations identified to date are null mutations, which are predicted to cause the pathology via haploinsufficiency. Decreased peripheral progranulin protein (PGRN) levels are associated with the presence of GRN null mutations and are accepted as reliable biomarkers. In this study, our aim was to test whether the presence of specific GRN splice site mutations (c.– 8+2T>G and c.708+6_9del), could be predicted by peripheral mRNA or protein GRN levels, by studying affected and asymptomatic individuals from FTD families. We also tested four missense GRN variants to assess if altered GRN levels depended on the type of mutation.
Our results confirmed a reduction in both mRNA and protein PGRN levels in the splice site mutation carriers, which is consistent with previous reports for null mutations. Our results also suggested that both decreased peripheral GRN mRNA and serum PGRN levels indicate the presence of pathogenic mutations in affected individuals, and identify the asymptomatic individuals at risk, without previous knowledge of genetic status. Both inferences suggest a potential use of peripheral GRN mRNA or serum PGRN levels as biomarkers for families with FTD.
CrutsM, GijselinckI, van der Zee J, EngelborghsS, WilsH, PiriciD, RademakersR, VandenbergheR, DermautB, MartinJJ, van Duijn C, PeetersK, SciotR, SantensP, De Pooter T, MattheijssensM, Van den Broeck M, CuijtI, VennekensK, De Deyn PP, Kumar-SinghS, Van Broeckhoven C (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature442, 920–924.
4.
SassiC, CapozzoR, GibbsR, CrewsC, ZeccaC, ArcutiS, CopettiM, BarulliMR, BresciaV, SingletonAB, LogroscinoG (2016) A novel splice-acceptor site mutation in GRN (c.709-2 A>T) causes frontotemporal dementia spectrum in a large family from Southern Italy. J Alzheimers Dis53, 475–485.
5.
MendezMF (2018) Manic behavior and asymmetric right frontotemporal dementia from a novel progranulin mutation. Neuropsychiatr Dis Treat14, 657–662.
6.
Van LangenhoveT, van der ZeeJ, GijselinckI, EngelborghsS, VandenbergheR, VandenbulckeM, De BleeckerJ, SiebenA, VersijptJ, IvanoiuA, DeryckO, WillemsC, DillenL, PhiltjensS, MaesG, BaumerV, Van Den Broeck M, MattheijssensM, PeetersK, MartinJJ, MichotteA, SantensP, De Jonghe P, CrasP, De Deyn PP, CrutsM, Van Broeckhoven C (2013) Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. JAMA Neurol70, 365–373.
7.
SleegersK, BrouwersN, Van Damme P, EngelborghsS, GijselinckI, van der Zee J, PeetersK, MattheijssensM, CrutsM, VandenbergheR, De Deyn PP, RobberechtW, Van Broeckhoven C (2009) Serum biomarker for progranulin-associated frontotemporal lobar degeneration. Ann Neurol65, 603–609.
8.
SchofieldEC, HallidayGM, KwokJ, LoyC, DoubleKL, HodgesJR (2010) Low serum progranulin predicts the presence of mutations: A prospective study. J Alzheimers Dis22, 981–984.
9.
AlmeidaMR, BaldeirasI, RibeiroMH, SantiagoB, MachadoC, MassanoJ, GuimaraesJ, Resende Oliveira C, SantanaI (2014) Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a Portuguese cohort. Neurodegener Dis13, 214–223.
10.
FinchN, BakerM, CrookR, SwansonK, KuntzK, SurteesR, BisceglioG, Rovelet-LecruxA, BoeveB, PetersenRC, DicksonDW, YounkinSG, DeramecourtV, CrookJ, Graff-RadfordNR, RademakersR (2009) Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain132, 583–591.
11.
GhidoniR, StoppaniE, RossiG, PiccoliE, AlbertiniV, PaterliniA, GlionnaM, PegoianiE, AgnatiLF, FenoglioC, ScarpiniE, GalimbertiD, MorbinM, TagliaviniF, BinettiG, BenussiL (2012) Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: A multicenter Italian study. Neurodegener Dis9, 121–127.
12.
GalimbertiD, FumagalliGG, FenoglioC, CioffiSMG, ArighiA, SerpenteM, BorroniB, PadovaniA, TagliaviniF, MasellisM, TartagliaMC, van Swieten J, MeeterL, GraffC, de Mendonca A, BocchettaM, RohrerJD, ScarpiniE (2018) Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: Results from the GENFI study. Neurobiol Aging62, 245.e9–245.e12.
MeeterLH, PatzkeH, LoewenG, DopperEG, PijnenburgYA, van MinkelenR, van Swieten JC (2016) Progranulin levels in plasma and cerebrospinal fluid in granulin mutation carriers. Dement Geriatr Cogn Dis Extra6, 330–340.
15.
GuvenG, LohmannE, BrasJ, GibbsJR, GurvitH, BilgicB, HanagasiH, RizzuP, HeutinkP, EmreM, Erginel-UnaltunaN, JustW, HardyJ, SingletonA, GuerreiroR (2016) Mutation frequency of the major frontotemporal dementia genes, MAPT, GRN and C9ORF72 in a Turkish cohort of dementia patients. Plos One11, e0162592.
16.
AdzhubeiIA, SchmidtS, PeshkinL, RamenskyVE, GerasimovaA, BorkP, KondrashovAS, SunyaevSR (2010) A method and server for predicting damaging missense mutations. Nat Methods7, 248–249.
17.
SchwarzJM, CooperDN, SchuelkeM, SeelowD (2014) MutationTaster2: Mutation prediction for the deep-sequencing age. Nat Methods11, 361–362.
18.
ChoiY, SimsGE, MurphyS, MillerJR, ChanAP (2012) Predicting the functional effect of amino acid substitutions and indels. Plos One7, e46688.
19.
YeoG, BurgeCB (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol11, 377–394.
20.
Le Ber I, Van der ZeeJ, HannequinD, GijselinckI, CampionD, PuelM, LaquerriereA, De Pooter T, CamuzatA, Van den Broeck M, DuboisB, SellalF, LacomblezL, VercellettoM, Thomas-AnterionC, MichelBF, GolfierV, DidicM, SalachasF, DuyckaertsC, CrutsM, VerpillatP, Van BroeckhovenC, BriceA,
French Research Network on FTD/FTD-MND (2007) Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat28, 846–855.
21.
BrouwersN, NuytemansK, van der Zee J, GijselinckI, EngelborghsS, TheunsJ, Kumar-SinghS, PickutBA, PalsP, DermautB, BogaertsV, De Pooter T, SerneelsS, Van den Broeck M, CuijtI, MattheijssensM, PeetersK, SciotR, MartinJJ, CrasP, SantensP, VandenbergheR, De Deyn PP, CrutsM, Van Broeckhoven C, SleegersK (2007) Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch Neurol64, 1436–1446.
22.
JanssensJ, PhiltjensS, KleinbergerG, Van Mossevelde S, van der Zee J, CacaceR, EngelborghsS, SiebenA, Banzhaf-StrathmannJ, DillenL, MerlinC, CuijtI, RobberechtC, SchmidB, SantensP, IvanoiuA, VandenbulckeM, VandenbergheR, CrasP, De Deyn PP, MartinJJ, MaudsleyS, HaassC, CrutsM, Van BroeckhovenC (2015) Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains. Acta Neuropathol Commun3, 68.
BrouwersN, SleegersK, EngelborghsS, Maurer-StrohS, GijselinckI, van der Zee J, PickutBA, Van den BroeckM, MattheijssensM, PeetersK, SchymkowitzJ, RousseauF, MartinJJ, CrutsM, De Deyn PP, Van BroeckhovenC (2008) Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology71, 656–664.
SleegersK, BrouwersN, Maurer-StrohS, van Es MA, Van Damme P, van Vught PW, van der Zee J, SerneelsS, De Pooter T, Van den Broeck M, CrutsM, SchymkowitzJ, De Jonghe P, RousseauF, van den BergLH, RobberechtW, Van Broeckhoven C (2008) Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology71, 253–259.
31.
WangJ, Van Damme P, CruchagaC, GitchoMA, VidalJM, Seijo-MartinezM, WangL, WuJY, RobberechtW, GoateA (2010) Pathogenic cysteine mutations affect progranulin function and production of mature granulins. J Neurochem112, 1305–1315.
32.
CoppolaG, KarydasA, RademakersR, WangQ, BakerM, HuttonM, MillerBL, GeschwindDH (2008) Gene expression study on peripheral blood identifies progranulin mutations. Ann Neurol64, 92–96.
